Manus Bio Revenue and Competitors

Boston, MA USA

Location

$94.8M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Manus Bio's estimated annual revenue is currently $27.7M per year.(i)
  • Manus Bio's estimated revenue per employee is $193,750
  • Manus Bio's total funding is $94.8M.

Employee Data

  • Manus Bio has 143 Employees.(i)
  • Manus Bio grew their employee count by 12% last year.

Manus Bio's People

NameTitleEmail/Phone
1
VP QualityReveal Email/Phone
2
VP Global Sales - N.America/Latam/EAMEReveal Email/Phone
3
VP R&DReveal Email/Phone
4
Head, Pharma Therapeutics/Manufacturing Platforms - Science and Business developmentReveal Email/Phone
5
Director Facilities & EngineeringReveal Email/Phone
6
Chief Business OfficerReveal Email/Phone
7
Site Security DirectorReveal Email/Phone
8
Senior Director Human ResourcesReveal Email/Phone
9
Senior Director R&DReveal Email/Phone
10
Chief Financial OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Manus Bio?

MAKING NATURE ACCESSIBLE AND AFFORDABLE FOR A GROWING SOCIETY. It is estimated that the world's population will increase by more than 35% by 2050, reaching 9 billion people. Crop production will need to more than double in order to feed these people and meet the consumer needs of a developing world. With very little land remaining for agricultural expansion, we as a society need to find ways to maximize the use of our world's resources. Plants produce a variety of rare natural products which are used in our daily lives as flavors, fragrances, food ingredients, cosmetics, vitamins, pharmaceuticals and agricultural chemicals. We strive to reduce our dependence on land- and resource-intensive practices by recreating natural processes through biotechnology. SUSTAINABILITY: We provide a renewable and stable supply of natural plant ingredients through fermentation, which frees up agricultural land for food production and protects non-cultivatable plant species from extinction. ACCESS: We reduce costs by more than 10-fold, allowing easier adoption and access to these natural ingredients across the world. We also ensure consistent quality and dependable quantities no matter what the adverse environmental or climate conditions (droughts, frost, diseases) might be. DIVERSITY: Replicating plant natural processes in bacteria allows us to benefit from nature's enormous diversity without threatening natural ecosystems and existing biodiversity. In essence, we tap into nature without harming nature.

keywords:Biotechnology,Food & Beverages,Healthcare,Household & Personal Products,Personal Products

$94.8M

Total Funding

143

Number of Employees

$27.7M

Revenue (est)

12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Manus Bio News

2022-04-17 - Lactobionic Acid Consumption Market Size, Share, Growth ...

... Market Size, Share, Growth 2022-2029| Key Players – Reliable Biopharmaceutical, Global Lactobionic Acid, Bio-sugars Technology, Manus Aktteva Biopharma.

2020-11-17 - Manus Bio Raises $75M in Series B Financing to Expand Biomanufacturing Platform for Natural Ingredients

CAMBRIDGE, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Manus Bio Inc. (Manus Bio), a leader in the production of complex natural products through advanced fermentation, has raised $75M in Series B financing to expand its advanced fermentation platform for manufacturing natural ingredients. This rou ...

2020-11-17 - Manus Bio Raises $75M in Series B Financing

Manus Bio Inc., a Cambdridge, Mass.-based maker of complex natural products through advanced fermentation, raised $75M in Series B financing. The round was led by a new strategic partner, BBGI Public Company Limited (BBGI), a manufacturer and distributor of bio-based products based in Bangkok, ...

2020-11-17 - Manus Bio Raises $75M in Series B

CAMBRIDGE, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Manus Bio Inc., a leader in the production of complex natural products through advanced fermentation, has raised $75M in Series B financing to expand its advanced fermentation platform for manufacturing natural ingredients. This round was led b ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.4M1435%N/A
#2
$41.5M14336%N/A
#3
$50.8M1438%N/A
#4
$22.4M1440%$100M
#5
$45.9M144-7%N/A